Enzo Biochem, Inc. (ENZ)

NYSE: ENZ · IEX Real-Time Price · USD
2.38
0.03 (1.28%)
May 16, 2022 4:00 PM EDT - Market closed
Market Cap115.93M
Revenue (ttm)118.18M
Net Income (ttm)300,000
Shares Out48.71M
EPS (ttm)0.01
PE Ratio396.67
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,990
Open2.39
Previous Close2.35
Day's Range2.37 - 2.45
52-Week Range2.23 - 4.15
Beta0.78
AnalystsBuy
Price Targetn/a
Earnings DateJun 8, 2022

About ENZ

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides...

IndustryHealth Care Providers & Services
Founded1976
CEOElazar Rabbani
Employees451
Stock ExchangeNYSE
Ticker SymbolENZ
Full Company Profile

Financial Performance

Financial Statements

News

Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal

Meeting Scheduled for April 8, 2022 at 9:00 AM ET

1 month ago - GlobeNewsWire

Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022

NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced its 2021 Annual Meeting of Share...

1 month ago - GlobeNewsWire

Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions

NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced two key appointments to its new ...

1 month ago - GlobeNewsWire

Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates

Conference call and live webcast scheduled for today, Monday, March 14, 2022 at 4:30 pm (ET)

2 months ago - GlobeNewsWire

Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Market...

2 months ago - GlobeNewsWire

Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th

Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET

2 months ago - GlobeNewsWire

Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem's Board of Directors

NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfania...

4 months ago - GlobeNewsWire

Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update

Conference call and live webcast scheduled for today, Wednesday, December 15, 2021 at 4:30 pm (ET)

5 months ago - GlobeNewsWire

Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th

Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET

5 months ago - GlobeNewsWire

ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER

NEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it grant...

6 months ago - GlobeNewsWire

Bradley L. Radoff Issues Letter to the Independent Directors of Enzo Biochem Regarding Their Unwillingness to Acknowl...

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who together with his affiliates holds approximately 7.5% of the outstanding common shares of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company"), today...

6 months ago - Business Wire

Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexuall...

GoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and herpes

6 months ago - GlobeNewsWire

Bradley L. Radoff Issues Open Letter to Recently-Appointed Independent Directors of Enzo Biochem

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who together with his affiliates holds approximately 7.2% of the outstanding common shares of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company"), today...

6 months ago - Business Wire

HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIA...

Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer

6 months ago - GlobeNewsWire

Enzo Biochem Clocks 27% Revenue Growth In Q4, Margin Remains Stable

Biosciences and diagnostics company Enzo Biochem Inc (NYSE: ENZ) reported fourth-quarter FY21 revenue growth of 27% year-on-year to $24.8 million. Revenue decreased 24% sequentially.

7 months ago - Benzinga

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update

Conference call and live webcast scheduled for today, Tuesday, October 12, 2021 at 8:30 am (ET)

7 months ago - GlobeNewsWire

Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th

Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET

7 months ago - GlobeNewsWire

FDA Expands EUA For Rapid Extraction On One COVID-19 Test System

Enzo Biochem Inc (NYSE:ENZ) has received an expansion of its FDA Emergency Use Authorization (EUA) for its rapid extraction method on its Ampiprobe SARS-CoV-2 Test System to detect SARS-CoV-2, including...

9 months ago - Benzinga

Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel

Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel.

11 months ago - GlobeNewsWire

Enzo Biochem Reports Third Quarter Fiscal 2021 Results

Conference call and live webcast scheduled for today, Wednesday, June 9, 2021 at 4:30 PM (ET).

11 months ago - GlobeNewsWire

Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9

Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET

11 months ago - GlobeNewsWire

Enzo's Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use...

Company's specimen collection kit now available for use in COVID-19 testing in the U.S.

1 year ago - GlobeNewsWire

Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates

Conference call and live webcast scheduled for today, Monday, March 15, 2021 at 4:30 pm (ET)

1 year ago - GlobeNewsWire

Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference

NEW YORK, NY, March 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present at ...

1 year ago - GlobeNewsWire

Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15

Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET

1 year ago - GlobeNewsWire